
91.47 Delayed Data As of Apr 09 | ![]() Today’s Change | 30.00 Today|||52-Week Range 96.54 | +25.04% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $20.5B |
Horizon Therapeutics Plc Connaught House Dublin Dublin 4 |
Timothy P. Walbert | Chairman, President & Chief Executive Officer |
Paul W. Hoelscher | Chief Financial Officer & Executive Vice President |
Jeffrey W. Sherman | Chief Medical Officer & Executive Vice President |
Jeffrey D. Kent | Executive VP-Medical Affairs & Outcomes Research |
Karin Rosen | Chief Scientific Officer |